Ajanta Pharma secures FDA approval for Topiramate Capsules, eyes 2026 market launch
Ajanta Pharma Limited, a leading specialty pharmaceutical formulation company, has won a decisive victory by gaining final approval from the United States Food and Drug Administration (FDA) to market Topiramate Extended-Release Capsules. Available in four different potencies—25 mg, 50 mg, 100 mg, and 200 mg—the Topiramate capsules are the generic version of Supernus Pharmaceuticals Inc’s […]